MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Regular Strength Aspirin

Selected References:  

  1. Center for Drug Evaluation and Research. (n.d.). NSAIDs may cause rare kidney problems in unborn babies. Retrieved July 11, 2023, from https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
  2. Committee on Drugs, American Academy of Pediatrics. 2001. The transfer of drugs and other chemicals into human breast milk. Pediatrics, 108:776-789.
  3. Czeizel AE, et al. 2000. A population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy. Pharmacoepidemiol Drug Saf, 9:193-205.
  4. FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications. 2020. https://www.fda.gov/news-events/press-announcements/fda-warns-using-type-pain-and-fever-medication-second-half-pregnancy-could-lead-complications?utm_medium=email&utm_source=govdelivery
  5. Findlay JWA, et al. 1981. Analgesic drugs breast milk and plasma. Clin Pharmacol Ther, 29:625-33.
  6. Hastie R, et al. 2021. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. Am J Obstet Gynecol, 224(1):95.e1-95.e12.
  7. Hernandez RK, et al. 2012. Nonsteroidal anti-inflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol, 206(3):228.e1-8.
  8. Jamali F, Keshavarz E. 1981. Salicylate in breast milk. Int J Pharm, 8:285-290.
  9. Killick S, Elstein M. 1987. Pharmacological production of luteinized unruptured follicles by prostaglandin synthetase inhibitors. Fertil Steril, 47:773-777.
  10. Kozer E, et al. 2002. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. Am J Obstet Gynecol, 187:1623-1630.
  11. Levin DL, et al. 1978. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr, 92:478-483.
  12. Lewis RB, Schulman JD. 1973. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labor. Lancet, 2:1159-1163.
  13. Li DK, et al. 2003. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ, 327:368-370.
  14. Martinez-Frias ML, et al. 1997. Prenatal exposure to salicylates and gastroschisis: a case-control study. Teratology, 56:241-243.
  15. Norgard B, et al. 2005. Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol, 192:922-923.
  16. Petersen TG, et al. 2018. Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child. Int J Epidemiol, 47(1):121-130.
  17. Rumack CM, et al. 1981. Neonatal intracranial hemorrhage and maternal use of aspirin. Obstet Gynecol, 58(Suppl):52S-56S.
  18. Slone D, et al. 1976. Aspirin and congenital malformations. Lancet, 1(7974):1373-1375.
  19. The WHO Working Group, Bennet PN (ed). 1988. Drugs and Human Lactation. Elsevier, Amsterdam, New York, Oxford. pp. 325-326.
  20. Torfs CP, et al. 1996. Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology, 54:84-92.
  21. Turner G, Collins E. 1975. Fetal effects of regular salicylate ingestion during pregnancy. Lancet, 2:338-339.
  22. Tyler CP, et al. 2012. Brain damage in preterm newborns and maternal medication: the ELGAN study. Am J Obstet Gynecol, 207:192e1-9.
  23. Werler MM, et al. 1989. The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med, 321:1639-42.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.